MENINGIOMA, MALIGNANT
Clinical trials for MENINGIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MENINGIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MENINGIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach aims to stop brain tumor regrowth
Disease control Recruiting nowThis pilot trial is testing a type of radiation called hypofractionated stereotactic radiosurgery for people who have had surgery for a grade II or recurrent grade I meningioma. The treatment delivers higher doses of radiation in fewer sessions, which may kill leftover tumor cell…
Matched conditions: MENINGIOMA, MALIGNANT
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Cancer pill shows promise against tough brain tumor
Disease control Recruiting nowThis phase 2 trial tests whether the drug regorafenib can slow tumor growth in people with recurrent meningioma, a type of brain tumor. About 104 participants will receive either regorafenib or standard care. The main goal is to see how long the tumor stays under control.
Matched conditions: MENINGIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC